AVAH logo

Aveanna Healthcare Holdings Inc. (AVAH)

$11.65

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on AVAH

Market cap

$2.54B

EPS

1.4

P/E ratio

9.7

Price to sales

1.03

Dividend yield

--

Beta

2.035093

Price on AVAH

Previous close

$11.63

Today's open

$11.63

Day's range

$11.57 - $12.04

52 week range

$5.93 - $14.71

Profile about AVAH

CEO

Jeffrey Shaner

Employees

35500

Headquarters

Atlanta, GA

Exchange

Nasdaq Global Select

Shares outstanding

218409599

Issue type

Common Stock

AVAH industries and sectors

Healthcare

Healthcare Providers & Services

News on AVAH

Healthcare Stocks Overtake Tech: 5 Strong Buys Combining Growth And Value

Healthcare's emerging leadership combines defensive demand with long-term growth; the sector has gained over 22% year-to-date and more than 11% over one month. Five Quant Strong Buy stocks in the sector offer compelling growth opportunities, supported by strong earnings momentum, improving profitability, and positive analyst revisions. Healthcare services benefit from aging demographics, expanding patient demand, technological innovation, and operating efficiencies that support revenue growth and margin expansion.

news source

Seeking Alpha • Nov 17, 2026

news preview

Aveanna Healthcare: Q3 Beat And Higher Guidance Back Strong Buy Rating

Aveanna Healthcare dipped despite a double earnings beat, but the growth outlook remains strong, backed by bullish Wall Street revisions. Private duty services drove earnings growth with hours of care increasing by more than double digits to 13 million amid a shift toward preferred payers. Revenue increased over 11% YoY in Q3 while adjusted EBITDA surged 25%, as the company demonstrated solid operating leverage.

news source

Seeking Alpha • Nov 13, 2026

news preview

Should Value Investors Buy Aveanna Healthcare (AVAH) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

news source

Zacks Investment Research • Nov 13, 2026

news preview

What Aveanna Healthcare (AVAH) Said on Its Q3 Earnings Call

Aveanna Healthcare NASDAQ: AVAH raised its full-year 2026 outlook after reporting third-quarter revenue growth across all three of its businesses and a 25% increase in adjusted earnings.

news source

MarketBeat • Nov 12, 2026

news preview

Aveanna Healthcare Holdings Inc. (AVAH) Q3 2026 Earnings Call Transcript

Aveanna Healthcare Holdings Inc. ( AVAH ) Q3 2026 Earnings Call November 12, 2026 10:00 AM EST Company Participants Debbie Stewart - Senior VP & Principal Accounting Officer Jeffrey Shaner - President, CEO & Director Matt Buckhalter - CFO & Principal Financial Officer Conference Call Participants Meghan Holtz - Jefferies LLC, Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Raj Kumar - Stephens Inc., Research Division Sean Dodge - BMO Capital Markets Equity Research Pito Chickering - Deutsche Bank AG, Research Division Benjamin Rossi - JPMorgan Chase & Co, Research Division Jared Haase - William Blair & Company L.L.C., Research Division Andrew Cooper - Raymond James Wealth Management Limited, Asset Management Arm Presentation Operator Good morning, and welcome to Aveanna Healthcare Holdings Third Quarter 2026 Earnings Conference Call.

news source

Seeking Alpha • Nov 12, 2026

news preview

Aveanna Healthcare: Revenue Growth, Guidance Raises, Yet Shares Still Trade At A Discount

Aveanna Healthcare is rated Buy due to double-digit revenue growth, improved overhead leverage, and a favorable upcoming California rate increase. AVAH trades at a ~20% earnings discount to sector peers, reflecting concerns over leverage and Medicaid exposure, but the market underappreciates its growth. Rising caregiver wages, expanding nursing hours, and operational efficiencies support further upside, with California's 2027 rate hike as a credible tailwind.

news source

Seeking Alpha • Nov 13, 2026

news preview

Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2026 Guidance

ATLANTA, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three and nine-month periods ended October 3, 2026.

news source

GlobeNewsWire • Nov 12, 2026

news preview

Aveanna Healthcare (AVAH) Q3 Earnings and Revenues Beat Estimates

Aveanna Healthcare (AVAH) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.15 per share a year ago.

news source

Zacks Investment Research • Nov 12, 2026

news preview

Compared to Estimates, Aveanna (AVAH) Q3 Earnings: A Look at Key Metrics

The headline numbers for Aveanna (AVAH) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

news source

Zacks Investment Research • Nov 12, 2026

news preview

Aveanna Healthcare Just Keeps Raising The Bar

Aveanna Healthcare Holdings Inc. delivered another strong quarter, beating top- and bottom-line expectations and raising FY 2026 revenue and EBITDA guidance. AVAH's adjusted EBITDA grew 25% year-over-year, with margin expansion to 14.4%, demonstrating significant operating leverage and improved cash flow. Despite a substantial debt load and reimbursement risks, AVAH trades at the lowest forward PE and price-to-cash flow ratios among peers, reinforcing its Buy rating.

news source

Seeking Alpha • Nov 12, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Aveanna Healthcare Holdings Inc.

Open an M1 investment account to buy and sell Aveanna Healthcare Holdings Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in AVAH on M1